A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease

Michelle J Nichols, Johanna M Hartlein, Meredith GA Eicken, Brad A Racette, Kevin J Black
  • F1000Research, July 2013, Faculty of 1000, Ltd.
  • DOI: 10.12688/f1000research.2-150.v1

Olanzapine for psychosis in Parkinson disease

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.12688/f1000research.2-150.v1

The following have contributed to this page: Dr Kevin J. Black